Sternchemie has received a GRAS “letter of no objection” from the US Food and Drug Administration (FDA) for its wide range of sunflower lecithins. GRAS stands for “Generally Recognised As Safe” and provides certainty and transparency for food manufacturers. With this determination, the FDA confirms that sunflower lecithin from Sternchemie, whether liquid, de-oiled or hydrolysed, can safely be used in a wide variety of food products.
TurtleTree Becomes First to Receive FDA Clearance for Precision-Fermented Lactoferrin
California-based biotech company TurtleTree has secured a “No Questions” letter from the US Food and Drug Administration (FDA) for its precision fermentation-produced lactoferrin, referred to as LF+. This correspondence indicates that the FDA has completed its review of TurtleTree’s Generally Recognized as Safe (GRAS) dossier without raising any safety concerns, allowing the ingredient to be used in food products within the United States. The FDA’s assessment of LF+ encompassed genomic, toxicological, compositional, and functional analyses, which formed part of the GRAS submission. The agency’s “No Questions” letter confirms that the agency has no further inquiries regarding the ingredient’s safety under the intended conditions of use. Fengru Lin, CEO and co-founder of TurtleTree, commented on the FDA’s decision, noting its significance for the company and the …